The reference electrophysiological pattern at seizure onset is the "rapid discharge," as visible on intracerebral electroencephalography (EEG). This discharge typically corresponds to a decrease of synchrony across brain areas. In contrast, the preictal period can exhibit patterns of increased synchrony, which can be quantified by network measures. Our objective was to compare preictal synchrony with a quantification of the rapid discharge as provided by the epileptogenicity index (EI). We investigated 24 seizures from 12 patients recorded by stereotaxic EEG (SEEG). Seizures were classified visually as containing preictal synchrony or not. We computed pairwise nonlinear correlation (h(2)) across channels in the 8 sec preceding the rapid discharge. The sum of ingoing and outgoing links (IN and OUT node strength), as well as the sum of all links (total strength, TOT) were computed for each region. We tested several filtering schemes, and quantified the capacity of each strength measure to serve as a detector of regions with high EI values using a receiver operating characteristic (ROC) analysis. We found that the best correspondence between node strength and EI was obtained for the OUT and TOT measures, for signals filtered in the 15-40 Hz band-that is, for the band corresponding to the spiky part of epileptic discharges. In agreement with these results, we also found that the ROC results were improved when considering only seizures with visible synchronous patterns in the preictal period. Our results suggest that measuring strength of preictal connectivity graphs can bring useful clinical information on the epileptogenic zone.
BackgroundCongenital cytomegalovirus infections are a leading cause of neurodevelopmental disorders in human and represent a major health care and socio-economical burden. In contrast with this medical importance, the pathophysiological events remain poorly known. Murine models of brain cytomegalovirus infection, mostly neonatal, have brought recent insights into the possible pathogenesis, with convergent evidence for the alteration and possible involvement of brain immune cells.Objectives and MethodsIn order to confirm and expand those findings, particularly concerning the early developmental stages following infection of the fetal brain, we have created a model of in utero cytomegalovirus infection in the developing rat brain. Rat cytomegalovirus was injected intraventricularly at embryonic day 15 (E15) and the brains analyzed at various stages until the first postnatal day, using a combination of gene expression analysis, immunohistochemistry and multicolor flow cytometry experiments.ResultsRat cytomegalovirus infection was increasingly seen in various brain areas including the choroid plexi and the ventricular and subventricular areas and was prominently detected in CD45low/int, CD11b+ microglial cells, in CD45high, CD11b+ cells of the myeloid lineage including macrophages, and in CD45+, CD11b– lymphocytes and non-B non-T cells. In parallel, rat cytomegalovirus infection of the developing rat brain rapidly triggered a cascade of pathophysiological events comprising: chemokines upregulation, including CCL2-4, 7 and 12; infiltration by peripheral cells including B-cells and monocytes at E17 and P1, and T-cells at P1; and microglia activation at E17 and P1.ConclusionIn line with previous findings in neonatal murine models and in human specimen, our study further suggests that neuroimmune alterations might play critical roles in the early stages following cytomegalovirus infection of the brain in utero. Further studies are now needed to determine which role, whether favorable or detrimental, those putative double-edge swords events actually play.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.